A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects

• Autores principales: Xingjiang Hu (Autor), Qiao Zhang (Autor), Yunliang Zheng (Autor), You Zhai (Autor), Nana Xu (Autor), Qingwei Zhao (Autor), Jian Liu (Autor), Longyan Wan (Autor), Jindan Luo (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Leuprolide acetate microspheres developed by Shanghai Livzon Pharmaceutical Co., Ltd. (T) have been marketed in China for more than 10 years, benefiting a large number of patients, and will continue to play an important role in China. However, as a generic drug, it is unclear whether there is a diff...